What is Shandong Weigao Blood Purification Products Co Net Margin %?
Shandong Weigao Blood Purification Products CoSHSE:603014 +9.99%38 Net Margin % is 13.08% as of Mar. 2026, which is 10% above its 10-year median of 11.85. GuruFocus rates SHSE:603014 with a GF Score™ of 38/100. The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Shandong Weigao Blood Purification Products Co ranks better than 79.19% on this metric.
SHSE:603014'
s Net Margin % Range Over the Past 10 Years
Min: 8.93 Med: 11.85 Max: 12.93
Current: 12.93
SHSE:603014's Net Margin % is ranked better than 79.19% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs SHSE:603014: 12.93
Shandong Weigao Blood Purification Products Co (SHSE:603014) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Shandong Weigao Blood Purification Products Co Net Margin % Related Terms
Shandong Weigao Blood Purification Products Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Blood Purification Products Co Net Margin % Chart
Shandong Weigao Blood Purification Products Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Blood Purification Products Co Net Margin % vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a Net Margin % of 13.08% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Shandong Weigao Blood Purification Products Co and its competitors. This is 10% above median its historical median of 11.85. Over the past decade, Shandong Weigao Blood Purification Products Co's Net Margin % has ranged from 8.93 to 12.93. According to the industry distribution chart, Shandong Weigao Blood Purification Products Co ranks #170 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 20.8%.
Is Shandong Weigao Blood Purification Products Co's Net Margin % too high?
Shandong Weigao Blood Purification Products Co's current Net Margin % of 13.08% is 10% above median its 10-year median of 11.85. Over the past 10 years, this metric has ranged from a low of 8.93 to a high of 12.93. The Medical Devices & Instruments industry median Net Margin % is 2.05. Shandong Weigao Blood Purification Products Co's value of 13.08% is 538% above this industry median. Based on the distribution chart, Shandong Weigao Blood Purification Products Co ranks #170 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Weigao Blood Purification Products Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Blood Purification Products Co's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Blood Purification Products Co ranks #170 out of 817 companies for Net Margin %. This places Shandong Weigao Blood Purification Products Co in the top 21% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.05. Shandong Weigao Blood Purification Products Co's value of 13.08% is 538% above this benchmark. Historically, Shandong Weigao Blood Purification Products Co's own Net Margin % has ranged from 8.93 to 12.93 over the past decade. While the company's 10-year median is 11.85 vs. the industry median of 2.05, Shandong Weigao Blood Purification Products Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Blood Purification Products Co's current Net Margin % of 13.08% is 538% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Shandong Weigao Blood Purification Products Co and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Blood Purification Products Co's current Net Margin % is 13.08%, which is 10% above median its own 10-year median of 11.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Blood Purification Products Co stock overvalued right now?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a current Net Margin % of 13.08%. The current Net Margin % is 13.08%, which is 10% above median its 10-year median of 11.85 and 538% above the Medical Devices & Instruments industry median of 2.05. Shandong Weigao Blood Purification Products Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Shandong Weigao Blood Purification Products Co (SHSE:603014), the current Net Margin % is 13.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shandong Weigao Blood Purification Products Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603014 has been successfully added to your 
